Five Prime announces restructuring to focus on clinical development
Five Prime Therapeutics announced a corporate restructuring to focus resources on its development pipeline, comprising five clinical-stage cancer programs. The company is eliminating 41 current positions and expects cost-saving efforts will result in a$10 million reduction in net cash. January 15, 2019